LOL. Legacy shareholders Big Boy pants must come with Depends for this one.
They've been at this for thirty years! Another example of legacy common losing everything as management walks with millions. Enough of Going it alone! The way to do it (for common shareholders that is) is to partner on each disease for cash up front, then use the proceeds for the next trial. STOP diluting common and doing reverse splits. Get the treatment to the patients.
Market Data 
Markets 
